Brief: Alpha Cognition Secures Additional U.S. Patent For Zunveyl (Benzgalantamine)

Alpha Cognition

12/02/2025 13:35

Feb 12 (Reuters) - Alpha Cognition  ACOG.O :
    * ALPHA COGNITION SECURES ADDITIONAL U.S. PATENT FOR ZUNVEYL
(BENZGALANTAMINE) IN THE TREATMENT OF MILD TO MODERATE
ALZHEIMER’S DISEASE

Source text:  ID:nBw5Qvjy1a 
Further company coverage:  ACOG.O 

 ((Reuters.Briefs@thomsonreuters.com;))